Alisa Lask is a director of RVL Pharmaceuticals plc.
Person profile
Latest filings (excl ownership)
No filings
Latest ownership filings
Recent insider trades
Date | Company | Security | Transaction | Code | Indirect | 10b5-1 | $Price | #Shares | $Value | #Remaining |
---|---|---|---|---|---|---|---|---|---|---|
14 May 24 | NEPH Nephros | Stock Option Common Stock | Grant | Acquire A | No | No | 2.14 | 7,323 | 15.67 k | 7,323 |
13 Dec 23 | NEPH Nephros | Common Stock | Grant | Acquire A | No | No | 0 | 9,291 | 0.00 | 48,629 |
10 Aug 23 | RVLPQ RVL Pharmaceuticals | Ordinary Shares | Payment of exercise | Dispose F | No | No | 0.49 | 12,000 | 5.88 k | 112,557 |
5 Jul 23 | RVLPQ RVL Pharmaceuticals | Ordinary Shares | Grant | Acquire A | No | No | 0 | 40,000 | 0.00 | 124,557 |
5 Jan 23 | NEPH Nephros | Common Stock | Grant | Acquire A | No | No | 0 | 27,613 | 0.00 | 39,338 |
5 Jan 23 | NEPH Nephros | Stock Option Common Stock | Grant | Acquire A | No | No | 1.07 | 7,080 | 7.58 k | 7,080 |